Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme australia pty ltd - varicella vaccine - live; water for injections -

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - cholera vaccine (el-tor ogawa and inaba) - solution for injection - active: cholera vaccine (el-tor ogawa and inaba)

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - cholera vaccine (el-tor inaba and ogawa); salmonella typhi heat killed - solution for injection - active: cholera vaccine (el-tor inaba and ogawa) salmonella typhi heat killed

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - hpv type 6 l1 protein, quantity: 20 microgram; hpv type 11 l1 protein, quantity: 40 microgram; hpv type 16 l1 protein, quantity: 40 microgram; hpv type 18 l1 protein, quantity: 20 microgram - injection, suspension - excipient ingredients: aluminium; histidine; polysorbate 80; borax; water for injections; sodium chloride - gardasil is indicated in females aged 9 through 45 years* for the prevention of cervical, vulvar, vaginal and anal cancer, precancerous or dysplastic lesions, genital warts, and infection caused by human papillomavirus (hpv) types 6, 11, 16, and 18 (which are included in the vaccine). gardasil is indicated in males 9 through 26 years of age for the prevention of anal cancer, precancerous or dysplastic lesions, external genital lesions and infection caused by hpv types 6, 11, 16, and 18 (which are included in the vaccine). *immunogenicity studies have been conducted to link efficacy in females and males aged 16 to 26 years to the younger populations.

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - tinzaparin sodium 10000 anti-xa iu/ml - solution for injection - 10000 anti-xa iu/ml - active: tinzaparin sodium 10000 anti-xa iu/ml excipient: benzyl alcohol sodium acetate trihydrate water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - tinzaparin sodium 10000 anti-xa iu/ml - solution for injection - 10000 anti-xa iu/ml - active: tinzaparin sodium 10000 anti-xa iu/ml excipient: sodium acetate trihydrate sodium hydroxide water

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - tinzaparin sodium 20000 anti-xa iu/ml - solution for injection - 20000 anti-xa iu/ml - active: tinzaparin sodium 20000 anti-xa iu/ml excipient: benzyl alcohol sodium hydroxide sodium metabisulfite water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - tinzaparin sodium 20000 anti-xa iu/ml - solution for injection - 20000 anti-xa iu/ml - active: tinzaparin sodium 20000 anti-xa iu/ml excipient: sodium hydroxide sodium metabisulfite water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - micafungin 100mg - powder for injection - 100 mg - active: micafungin 100mg excipient: citric acid lactose nitrogen sodium hydroxide - treatment of invasive candidiasis in children & adults treatment of oesophageal candidiasis in adults, adolescents nlt 16 yrs of age, and elderly patients for whom intravenous therapy is appropriate prophylaxis of candida infection in children and adult patients undergoing allogenic haematopoietic stem cell transplantation or patients who are expected to have neutropenia (absolute neutrophil count below 500 cells per microliter) for 10 or more days

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - micafungin 50mg - powder for injection - 50 mg - active: micafungin 50mg excipient: citric acid lactose nitrogen sodium hydroxide - treatment of invasive candidiasis in children & adults treatment of oesophageal candidiasis in adults, adolescents nlt 16 yrs of age, and elderly patients for whom intravenous therapy is appropriate prophylaxis of candida infection in children and adult patients undergoing allogenic haematopoietic stem cell transplantation or patients who are expected to have neutropenia (absolute neutrophil count below 500 cells per microliter) for 10 or more days